David Siegel, MD, PHD

David Siegel, MD, PHD

Division Chief, Multiple Myeloma

Research Focus:
David Siegel, M.D., Ph.D., chief of the Division of Multiple Myeloma, is one of the nation’s foremost authorities on multiple myeloma. Most recently, Dr. Siegel served the lead investigator of the pivotal multi-center, phase IIb study involving 30 cancer centers in North America that led to the FDA’s fast-track approval of Kyprolis (carfilzomib) for relapsed multiple myeloma patients.

years treating myeloma: 35

Number of Myeloma Patients Treated Annually:

Details & contact info

John Theurer Cancer Center

92 2nd Street
Hackensack, NJ, United States, 7601

Phone: (201)-257-5041

View Full Physician Bio

View Website

Send a message to David Siegel, MD, PHD


Thanks to our Myeloma Crowd Community sponsors:

.                         .       .